Nereida Valero

1.3k total citations
50 papers, 923 citations indexed

About

Nereida Valero is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Nereida Valero has authored 50 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 27 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Nereida Valero's work include Mosquito-borne diseases and control (26 papers), Viral Infections and Vectors (21 papers) and Malaria Research and Control (10 papers). Nereida Valero is often cited by papers focused on Mosquito-borne diseases and control (26 papers), Viral Infections and Vectors (21 papers) and Malaria Research and Control (10 papers). Nereida Valero collaborates with scholars based in Venezuela, Spain and Ecuador. Nereida Valero's co-authors include Jesús Mosquera, Luz Marina Espina, Ernesto Bonilla, Melchor Álvarez‐Mon, Leonor Chacín‐Bonilla, Germán Áñez, Shirley Medina-Leendertz, Héctor Pons, Eduardo Reyes and Juan Pablo Rojas Hernández and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain Research.

In The Last Decade

Nereida Valero

45 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nereida Valero Venezuela 22 449 386 232 107 96 50 923
Luz Marina Espina Venezuela 14 314 0.7× 261 0.7× 84 0.4× 56 0.5× 38 0.4× 26 496
John J. Mooney United States 28 253 0.6× 144 0.4× 183 0.8× 80 0.7× 216 2.3× 50 1.8k
Lisa M. Alleva Australia 14 464 1.0× 111 0.3× 22 0.1× 209 2.0× 168 1.8× 17 1.1k
Jie Peng China 17 37 0.1× 556 1.4× 142 0.6× 170 1.6× 267 2.8× 66 1.5k
Mayra Pérez-Tapia Mexico 10 109 0.2× 97 0.3× 47 0.2× 26 0.2× 103 1.1× 21 535
Steven Specter United States 21 70 0.2× 285 0.7× 52 0.2× 376 3.5× 174 1.8× 70 1.3k
Laura Pérez‐Martínez Spain 20 138 0.3× 438 1.1× 16 0.1× 123 1.1× 165 1.7× 38 981
Joshua S. Lichtman United States 9 92 0.2× 257 0.7× 213 0.9× 71 0.7× 917 9.6× 11 1.4k
Sergio Ojeda United States 20 438 1.0× 592 1.5× 47 0.2× 508 4.7× 165 1.7× 60 1.4k
Danielle Aw United Kingdom 11 49 0.1× 122 0.3× 91 0.4× 176 1.6× 277 2.9× 13 1.3k

Countries citing papers authored by Nereida Valero

Since Specialization
Citations

This map shows the geographic impact of Nereida Valero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nereida Valero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nereida Valero more than expected).

Fields of papers citing papers by Nereida Valero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nereida Valero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nereida Valero. The network helps show where Nereida Valero may publish in the future.

Co-authorship network of co-authors of Nereida Valero

This figure shows the co-authorship network connecting the top 25 collaborators of Nereida Valero. A scholar is included among the top collaborators of Nereida Valero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nereida Valero. Nereida Valero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valero, Nereida, et al.. (2021). LINFOHISTIOCITOSIS HEMOFAGOCÍTICA ASOCIADA AL DENGUE GRAVE. 6(4). 65–75.
3.
Fernández, Miriam, et al.. (2019). La violencia doméstica: una experiencia adversa significativa con grandes complicaciones en el niño. 38(3). 3 indexed citations
5.
Mosquera, Jesús, et al.. (2015). Association of lipid profile alterations with severe forms of dengue in humans. Archives of Virology. 160(7). 1687–1692. 35 indexed citations
6.
Valero, Nereida, et al.. (2014). Differential Induction of Cytokines by Human Neonatal, Adult, and Elderly Monocyte/Macrophages Infected with Dengue Virus. Viral Immunology. 27(4). 151–159. 30 indexed citations
7.
Valero, Nereida, et al.. (2014). Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology. 452-453. 42–51. 62 indexed citations
8.
Valero, Nereida, et al.. (2009). Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Transactions of the Royal Society of Tropical Medicine and Hygiene. 104(1). 16–23. 61 indexed citations
9.
Valero, Nereida, et al.. (2008). Antagonistic Effect of Luzindole in Mice Treated with Melatonin During the Infection with the Venezuelan Equine Encephalomyelitis Virus. Neurochemical Research. 34(2). 268–273. 10 indexed citations
10.
Valero, Nereida, et al.. (2006). Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen. SHILAP Revista de lepidopterología.
11.
Áñez, Germán, et al.. (2006). Impacto económico del dengue y del dengue hemorrágico en el Estado de Zulia, Venezuela, 1997-2003. Revista Panamericana de Salud Pública. 19(5). 314–20. 34 indexed citations
12.
Valero, Nereida, Luz Marina Espina, & Jesús Mosquera. (2006). Melatonin Decreases Nitric oxide Production, Inducible Nitric oxide Synthase Expression and Lipid Peroxidation Induced by Venezuelan Encephalitis Equine Virus in Neuroblastoma Cell Cultures. Neurochemical Research. 31(7). 925–932. 17 indexed citations
14.
Valero, Nereida, et al.. (2005). Contribución del virus sincicial respiratorio y bacterias a la presencia de asma en una población adulta. Interciencia. 30(6). 356–360. 1 indexed citations
15.
Mosquera, Jesús, Juan Pablo Rojas Hernández, Nereida Valero, Luz Marina Espina, & Germán Áñez. (2005). Ultrastructural studies on dengue virus type 2 infection of cultured human monocytes. Virology Journal. 2(1). 26–26. 38 indexed citations
16.
Valero, Nereida, et al.. (2005). In Vitro, Melatonin Treatment Decreases Nitric Oxide Levels in Murine Splenocytes Cultured with the Venezuelan Equine Encephalomyelitis Virus. Neurochemical Research. 30(11). 1439–1442. 11 indexed citations
17.
Valero, Nereida, et al.. (2005). [Hepatic alterations in patients with dengue].. PubMed. 46(2). 169–78. 24 indexed citations
18.
Valero, Nereida, et al.. (2004). Seroprevalencia de la encefalitis equina venezolana en una población de équidos del estado Zulia, Venezuela, 1999-2001. SHILAP Revista de lepidopterología. -1(4). 0. 2 indexed citations
19.
Medina-Leendertz, Shirley, et al.. (2001). High Intensity Light Increases Olfactory Bulb Melatonin in Venezuelan Equine Encephalitis Virus Infection. Neurochemical Research. 26(3). 231–234. 5 indexed citations
20.
Bonilla, Ernesto, et al.. (2001). Melatonin prolongs survival of immunodepressed mice infected with the Venezuelan equine encephalomyelitis virus. Transactions of the Royal Society of Tropical Medicine and Hygiene. 95(2). 207–210. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026